Top Story

US cancer deaths continue to decline

US cancer deaths continue to decline
May 22, 2018
In the Journals Plus

Larotrectinib induces durable response in TRK fusion-positive pediatric cancer

May 9, 2018
Larotrectinib showed antitumor activity among infants and children with tropomyosin receptor kinases, or TRK, fusion-positive cancers, according to results of a phase 1…
FDA News

FDA grants orphan drug designation to cancer vaccine for rare bone tumor

May 2, 2018
The FDA granted orphan drug designation to the novel cancer vaccine BN-Brachyury for the treatment of chordoma, according to the agent’s manufacturer. Chordoma is…
FDA News

FDA places partial clinical hold on tazemetostat trials

April 25, 2018
The FDA placed a partial clinical hold on all clinical trials designed to evaluate tazemetostat, according to the drug’s manufacturer. The hold places a temporary…
More Headlines »

Ace the Case: A 48-Year-Old Woman Confused About a Diagnosis of Leukemia

There is no commercial support for this activity.

This “Ace the Case” activity will utilize a case study to discuss the assessment and management of a 48-year-old woman…
More »

Baseball great Mike Schmidt became ‘concerned about dying’ after melanoma diagnosis

September 25, 2017
More »
Resource Centers
Immuno-Oncology Resource Center

Immuno-Oncology Resource Center


Immune Checkpoint Inhibitors for Genitourinary Cancers: Practice Essential for Community Oncologists and Advanced Practice Providers

This activity is supported by an educational grant from Merck & Co., Inc.

For many years, the mainstay of initial treatment for metastatic bladder cancer has been chemotherapy. However…
More »